The US Food and Drug Administration (FDA) has recently rolled back certain regulatory requirements for lab-developed tests (LDTs), a decision that has sparked renewed discussions about clinical ivermectin studies 2025 usa , patient safety, regulatory accountability, and drug access. While LDTs ​​were previously held to strict FDA oversight standards, the rollback now allows...

The U.S. healthcare landscape is in a transformative phase. The rapid surge of GLP-1 obesity drugs and persistent discussions around ivermectin and GLP-1 healthcare discussions represent a clash of priorities in modern medicine. At the same time, the telehealth boom is changing how Americans access care, raising complex questions about health privacy,...

America is facing a maternal mortality crisis that has reached alarming levels in 2025. According to Wikipedia and leading U.S. health institutions, maternal death rates remain significantly higher than in other developed nations. Instead of focusing on evidence-based prenatal care, a dangerous distraction has emerged — Ivermectin myths, which have seeped...